International Multicentre, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Patients With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan

Trial Profile

International Multicentre, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Patients With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 Sep 2017

At a glance

  • Drugs Azilsartan medoxomil (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Sponsors Takeda
  • Most Recent Events

    • 11 Sep 2017 Planned End Date changed from 1 Apr 2018 to 1 Sep 2018.
    • 11 Sep 2017 Planned primary completion date changed from 1 Apr 2018 to 1 Sep 2018.
    • 23 Aug 2017 Planned End Date changed from 1 Mar 2018 to 1 Apr 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top